ALK and neuroblastoma: Outcome of neuroblastoma patients did not significantly depend on the type of ALK mutations, although OS of patients with F1174L mutations tended to be slightly worse than that of patients with tumors harboring other ALK mutations or ALK wildtype tumors (Supplementary Fig. 11a).